https://portalresearch.org/portal_work/portal-post-october-2025/ 2025-11-17T20:14:33+00:00 https://portalresearch.org/portal_work/patient-out%e2%80%90of%e2%80%90pocket-costs-following-the-availability-of-biosimilar-versions-of-infliximab-2/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/frequency-of-approval-and-marketing-of-biosimilars-with-a-skinny-label-and-associated-medicare-savings-2/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/climate-change-and-the-prescription-pad-2/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/op-ed-use-opioid-settlement-funds-to-educate-doctors/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/manufacturer-revenue-on-inhalers-after-expiration-of-primary-patents-2000-2021/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/estimated-medicare-part-b-savings-from-inflationary-rebates/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/therapeutic-value-of-drugs-frequently-marketed-using-direct-to-consumer-television-advertising-2015-to-2021/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/estimates-of-medicaid-and-non-medicaid-net-prices-of-top-selling-brand-name-drugs-incorporating-best-price-rebates-2015-to-2019/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/variation-in-use-of-lung-cancer-targeted-therapies-across-state-medicaid-programs-2020-2021/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/sources-of-innovation-in-gene-therapies-approaches-to-achieving-affordable-prices/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/simulated-medicare-drug-price-negotiation-under-the-inflation-reduction-act-of-2022/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/insulin-products-and-patents-in-the-usa-in-2004-2014-and-2020-a-cross-sectional-study/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/a-method-of-use-to-prevent-generic-and-biosimilar-market-entry/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/recent-patent-reform-bills-and-their-implications-for-prescription-drugs/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/characteristics-of-prior-authorization-policies-for-new-drugs-in-medicare-part-d/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/using-multiple-authorized-generics-to-maintain-high-prices-the-example-of-entacapone/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/us-public-investment-in-development-of-mrna-covid-19-vaccines-retrospective-cohort-study/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/trends-in-the-global-antibiotics-market/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/patent-challenges-and-litigation-on-inhalers-for-asthma-and-copd/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/estimated-medicaid-spending-on-original-and-citrate-free-adalimumab-from-2014-through-2021/ 2026-03-06T16:37:25+00:00 https://portalresearch.org/portal_work/medicaid-spending-on-antiretrovirals-from-2007-through-2019/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/analysis-of-risk-evaluation-and-mitigation-strategies-for-teratogenic-drugs-variation-in-primary-and-secondary-prevention-measures/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/the-right-to-repair-software-dependent-medical-devices/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/the-5-billion-hop-glatiramer-acetate-and-the-us-patent-system/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/a-methodology-for-estimating-medicaid-and-non-medicaid-net-prices-using-top-brand-name-drugs-2015-2019/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/eroding-judicial-deference-to-the-fda-consequences-for-public-health/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/op-ed-not-so-fast-on-covid-vaccine-price-hike/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/op-ed-is-it-business-as-usual-for-the-drug-industry/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/timing-of-confirmatory-trials-for-drugs-granted-accelerated-approval-based-on-surrogate-measures-from-2012-to-2021/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/alternatives-to-the-quality%e2%80%90adjusted-life-year-how-well-do-they-address-common-criticisms/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/acknowledging-infection-risk-in-bispecific-antibody-trials-in-the-treatment-of-multiple-myeloma/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/two-views-of-cancer-medicines-imagery-versus-evidence/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/trends-in-medicare-spending-on-oral-drugs-for-chronic-lymphocytic-leukemia-from-2014-to-2020/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/added-therapeutic-benefit-of-top-selling-brand-name-drugs-in-medicare/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/surrogate-measures-of-drug-efficacy-a-finger-pointing-at-the-moon/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/persistence-of-resistance-a-panel-data-analysis-of-the-effect-of-antibiotic-usage-on-the-prevalence-of-resistance/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/melflufen-post-hoc-subgroup-analyses-and-the-us-fda-oncologic-drugs-advisory-committee/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/federal-funding-for-discovery-and-development-of-costly-hiv-drugs-was-far-more-than-previously-estimated/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/concerns-about-climate-activism-in-clinical-practice-reply/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/medicare-price-negotiation-the-example-of-ibrutinib/ 2026-03-06T16:37:27+00:00 https://portalresearch.org/portal_work/five-year-sales-for-newly-marketed-prescription-drugs-with-and-without-initial-orphan-drug-act-designation/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/broad-patent-claims-come-before-the-supreme-court-in-amgen-v-sanofi/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/transferable-exclusivity-vouchers-and-incentives-for-antimicrobial-development-in-the-european-union/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/op-ed-how-the-makers-of-inhalers-keep-prices-so-high/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/inflationary-rebates-for-generic-drugs-sold-through-medicaid-saved-billions-during-2017-20/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/high-cost-of-chimeric-antigen-receptor-t-cells-challenges-and-solutions/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/health-technology-assessment-for-cancer-medicines-across-the-g7-countries-and-oceania-an-international-cross-sectional-study/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/an-empirical-review-of-key-glucose-monitoring-devices-product-iterations-and-patent-protection/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/medicare-drug-price-negotiation-few-drugs-big-impact/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/the-rise-and-fall-of-the-insulin-pricing-bubble/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/op-ed-new-alzheimers-drug-is-a-problem-for-fdas-pass-fail-approach/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/congress-misguided-plan-to-ban-qalys/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/the-prevalence-of-drug-patent-term-extensions-in-the-united-states-2000-2018/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/chronic-obstructive-pulmonary-disease-exacerbations-and-pneumonia-hospitalizations-among-new-users-of-combination-maintenance-inhalers/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/therapeutic-value-of-first-versus-supplemental-indications-of-drugs-in-us-and-europe-2011-20-retrospective-cohort-study/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/the-impact-of-electronic-health-record-discontinuity-on-prediction-modeling/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/physician-experiences-with-and-perceptions-of-risk-evaluation-and-mitigation-strategy-programs-with-elements-to-assure-safe-use/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/association-of-advisory-committee-votes-with-us-food-and-drug-administration-decision-making-on-prescription-drugs-2010-2021/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/op-ed-registry-enrollment-for-alzheimers-drug-coverage-wont-help-much/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/patenting-strategies-on-inhaler-delivery-devices/ 2026-03-06T16:37:29+00:00 https://portalresearch.org/portal_work/moving-naloxone-over-the-counter-is-necessary-but-not-sufficient/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/market-dynamics-of-authorized-generics-in-medicaid-from-2014-to-2020/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/comparative-effectiveness-and-safety-of-generic-versus-brand-name-fluticasone-salmeterol-to-treat-chronic-obstructive-pulmonary-disease/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/changes-in-the-number-of-continuation-patents-on-drugs-approved-by-the-fda/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/biosimilar-competition-for-humira-is-here-signs-of-hope-despite-early-hiccups/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/patents-and-regulatory-exclusivities-on-glp-1-receptor-agonists/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/gauging-the-value-of-top-selling-drugs-in-medicare-reply/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/340b-where-do-we-go-from-here/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/ensuring-ethical-postprogression-therapy-for-patients-in-randomized-trial-control-arms/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/the-regulatory-repercussions-of-approving-muscular-dystrophy-medications-on-the-basis-of-limited-evidence/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/securing-the-trustworthiness-of-the-fda-to-build-public-trust-in-vaccines/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/physician-perspectives-on-the-food-and-drug-administrations-decision-to-grant-accelerated-approval-to-aducanumab-for-alzheimers-disease/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/battles-over-medication-abortion-threaten-the-integrity-of-drug-approvals-in-the-us/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/authority-of-medicare-to-limit-coverage-of-fda-approved-products-legal-and-policy-considerations/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/variation-in-endpoints-in-fda-medication-approvals-a-review-of-acute-and-preventive-migraine-medications/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/the-accelerated-approval-program-for-cancer-drugs-finding-the-right-balance/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/three-key-ways-to-strengthen-proposed-pharmacy-benefit-manager-regulations/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/protecting-medicares-discretion-to-say-no-to-unproven-therapies/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/putting-the-pioneering-antimicrobial-subscriptions-to-end-upsurging-resistance-pasteur-act-under-the-microscope/ 2026-03-06T16:37:31+00:00 https://portalresearch.org/portal_work/the-340b-drug-pricing-program-administration-litigation-and-reform/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/trust-and-regulation-assuring-scientific-independence-in-the-fdas-emergency-use-authorization-process/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/regulatory-review-duration-and-differences-in-submission-times-of-drugs-in-the-united-states-and-europe-2011-to-2020/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/the-problem-of-limited-supply-agreements-for-medicare-price-negotiation/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/free-speech-challenges-to-the-inflation-reduction-act/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/infections-following-bispecific-antibodies-in-myeloma-a-systematic-review-and-meta-analysis/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/wedding-websites-free-speech-and-adverse-drug-effects/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/op-ed-we-cant-let-drug-companies-get-out-of-negotiating-prices/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/fairer-returns-on-public-investments/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/will-medicare-price-negotiation-delay-cancer-drug-launches/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/characteristics-of-post-hoc-subgroup-analyses-of-oncology-clinical-trials-a-systematic-review/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/confronting-high-costs-and-clinical-uncertainty-innovative-payment-models-for-gene-therapies/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/changes-in-induced-medical-and-procedural-abortion-rates-in-a-commercially-insured-population-2018-to-2022-an-interrupted-time-series-analysis/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/approval-and-therapeutic-value-of-gene-therapies-in-the-us-and-europe/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/reforming-pharmacy-benefit-managers-a-review-of-bipartisan-legislation/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/the-inflation-reduction-act-and-access-to-high-cost-cardiovascular-therapies/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/modernizing-federal-oversight-of-laboratory-developed-tests-toward-safety-validity-and-utility/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/national-comprehensive-cancer-network-guideline-recommendations-of-cancer-drugs-with-accelerated-approval/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/patents-and-regulatory-exclusivities-on-fda-approved-insulin-products-a-longitudinal-database-study-1986-2019/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/incorporating-information-on-therapeutic-alternatives-into-the-ira-prescription-drug-negotiations/ 2026-03-06T16:37:33+00:00 https://portalresearch.org/portal_work/outcomes-of-the-340b-drug-pricing-program-a-scoping-review/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/fda-and-chevron-deference-a-case-review/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/inequitable-conduct-and-invalidation-of-patents-related-to-food-and-drug-administration-regulated-products/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/ancillary-product-patents-to-extend-biologic-patent-life/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/overcoming-challenges-to-implementing-new-evidence-for-low-dose-anticoagulant-use-in-peripheral-artery-disease/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/building-public-trust-in-scientific-decision-making-through-expert-advisory-committees-lessons-from-the-fda/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/why-some-patients-overpay-for-specialty-generic-drugs/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/preserving-timely-generic-drug-competition-with-legislation-on-skinny-labeling/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/potential-medicare-and-medicaid-savings-on-anti-cd20-therapy-for-multiple-sclerosis/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/physicians-perspectives-on-fda-regulation-of-drugs-and-medical-devices-a-national-survey/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/crispr-phage-antibacterials-to-address-the-antibiotic-resistance-crisis-scientific-economic-and-regulatory-considerations/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/cost-of-exempting-sole-orphan-drugs-from-medicare-negotiation/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/complicated-regulatory-decision-making-following-inconsistent-trial-results-the-issue-with-ibrutinib-for-mantle-cell-lymphoma/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/improving-drug-supply-chain-security/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/biologic-patent-thickets-and-terminal-disclaimers/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/characteristics-of-patients-receiving-novel-muscular-dystrophy-drugs-in-trials-vs-routine-care/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/op-ed-how-much-do-physicians-really-know-about-fda-drug-and-device-regulation/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/independent-advice-on-drug-approvals-an-investigation-of-ema-practices/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/march-in-guidance-for-publicly-funded-drugs-a-necessary-safety-net-for-patients/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/identifying-therapeutic-alternatives-in-medicare-drug-price-negotiation-the-case-of-etanercept/ 2026-03-06T16:37:34+00:00 https://portalresearch.org/portal_work/estimated-spending-on-beremagene-geperpavec-for-dystrophic-epidermolysis-bullosa/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/biologic-patent-challenges-under-the-america-invents-act/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/administrative-action-on-drug-pricing-lessons-and-opportunities-for-the-center-for-medicare-and-medicaid-innovation/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/additional-steps-for-maintaining-public-trust-in-the-fda-reply/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/public-returns-on-public-investment-modernas-violation-of-the-social-contract/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/promoting-drug-and-vaccine-innovation-and-managing-high-prices-introducing-a-special-symposium/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/government-support-of-meaningful-drug-and-device-innovation-pathways-and-challenges/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/addressing-high-drug-prices-by-reforming-pharmacy-benefit-managers/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/delivery-device-patents-on-glp-1-receptor-agonists/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/the-constitutionality-of-medicare-drug-price-negotiation-under-the-takings-clause/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/patents-on-risk-evaluation-and-mitigation-strategies-for-prescription-drugs-and-generic-competition/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/direct-to-consumer-drug-company-pharmacies/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/patient-out-of-pocket-costs-for-biologic-drugs-after-biosimilar-competition/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/we-need-to-talk-about-values-a-proposed-framework-for-the-articulation-of-normative-reasoning-in-health-technology-assessment/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/use-of-efficiency-frontiers-to-align-prices-and-clinical-benefits-of-biologic-therapies-for-plaque-psoriasis/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/rates-and-costs-of-drug-testing-practices-for-private-payors-in-the-outpatient-setting-in-the-united-states-2015-2019/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/no-parking-here-a-review-of-generic-drug-180-day-exclusivity-and-recent-reform-proposals/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/federal-enforcement-of-pharmaceutical-fraud-under-the-false-claims-act-2006-2022/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/spending-on-targeted-therapies-for-duchenne-muscular-dystrophy/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/changes-in-use-of-hepatitis-c-direct-acting-antivirals-after-access-restrictions-were-eased-by-state-medicaid-programs/ 2026-03-06T16:37:36+00:00 https://portalresearch.org/portal_work/state-coverage-and-reimbursement-of-antiobesity-medications-in-medicaid/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/the-fda-in-the-crosshairs-science-politics-and-abortion/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/from-price-controls-to-robust-public-conversation-how-cms-can-move-drug-price-negotiation-into-the-light/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/the-value-of-the-quality-adjusted-life-years/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/clinical-value-of-molecular-targets-and-fda-approved-genome-targeted-cancer-therapies/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/clinical-benefit-and-regulatory-outcomes-of-cancer-drugs-receiving-accelerated-approval/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/use-of-artificial-intelligence-in-drug-development/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/medicare-should-cover-weight-loss-drugs-as-long-as-the-prices-are-affordable/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/medicare-negotiations-drug-reformulation-problem/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/how-health-technology-assessment-can-help-to-address-challenges-in-drug-repurposing-a-conceptual-framework/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/how-do-risk-evaluation-and-mitigation-strategies-impact-clinical-practice-a-national-survey-of-physicians/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/global-cooperation-and-early-access-clinical-outcomes-matter/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/estimated-medicare-part-d-savings-from-generic-drugs-with-a-skinny-label/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/patient-level-savings-on-generic-drugs-through-the-mark-cuban-cost-plus-drug-company/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/federal-trade-commission-actions-on-prescription-drugs-2000-2022/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/quantifying-research-and-development-expenditures-in-the-drug-industry/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/the-cost-of-drug-patent-expiration-date-errors/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/patent-portfolios-protecting-10-top-selling-prescription-drugs/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/measuring-and-understanding-market-exclusivity-length-for-new-prescription-drugs-in-france-australia-and-the-usa/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/biosimilar-approval-pathways-comparing-the-roles-of-five-medicines-regulators/ 2026-03-06T16:37:38+00:00 https://portalresearch.org/portal_work/removing-the-fdas-boxed-hepatotoxicity-warning-and-liver-function-testing-requirement-for-ambrisentan/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/use-of-track-one-prioritized-examination-for-pharmaceutical-patents/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/state-spending-targets-for-prescription-drugs/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/op-ed-this-gene-therapy-may-not-work-so-why-did-the-fda-fully-approve-it/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/misaligned-pharmacy-incentives-in-value-based-care/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/trust-in-the-food-and-drug-administration-a-national-survey-study/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/biosimilar-uptake-in-the-us-patient-and-prescriber-factors/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/revisiting-the-potential-of-money-blinds-lessons-from-lykoss-mdma-research/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/merging-medical-and-drug-benefits-seeing-the-whole-picture/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/the-origins-of-confidential-commercial-information-at-the-fda/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/clinical-value-of-guideline-recommended-molecular-targets-and-genome-targeted-cancer-therapies-cross-sectional-study/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/emulating-randomized-trials-by-observational-database-studies-the-rct-duplicate-initiative-in-copd-and-asthma/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/trends-in-use-and-evidence-of-adherence-to-risk-evaluation-and-mitigation-strategy-pregnancy-testing-requirements-for-thalidomide-lenalidomide-and-pomalidomide-in-the-usa-2000-2020/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/patient-perspectives-on-evidence-supporting-drug-safety-and-effectiveness-what-does-it-mean-for-me/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/letter-to-the-editor-re-life-years-gained-from-the-fda-accelerated-approval-program-in-oncology-a-portfolio-model/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/drug-repurposing-via-the-best-pharmaceuticals-for-children-act/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/commercial-markups-on-pediatric-oncology-drugs-at-340b-pediatric-hospitals/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/availability-and-cost-of-expensive-and-common-generic-prescription-drugs-a-cross-sectional-analysis-of-direct-to-consumer-pharmacies/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/the-double-edged-sword-of-extremely-high-prices-for-gene-therapies-in-sickle-cell-disease/ 2026-03-06T16:37:39+00:00 https://portalresearch.org/portal_work/extent-of-drug-patents-with-terminal-disclaimers-and-obviousness-type-double-patenting-rejections/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/price-and-variability-in-hospital-charges-for-generic-indomethacin-suppositories/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/use-of-omalizumab-for-pediatric-asthma-after-us-food-and-drug-administration-expanded-indications/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/the-race-act-and-pediatric-trials-of-adult-cancer-drugs/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/seeking-a-better-paper-trail-of-federal-research-funding/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/sales-revenues-for-new-therapeutic-agents-approved-by-the-united-states-food-and-drug-administration-from-1995-to-2014/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/patient-assistance-programs-a-new-era-of-law-and-policy/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/estimating-new-eligibility-and-maximum-costs-of-expanded-medicare-coverage-of-semaglutide-for-cardiovascular-risk-prevention/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/vaccine-messaging-by-the-fda-a-national-randomized-survey-study/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/confirmatory-trials-of-accelerated-approval-drugs-will-imposing-fines-reduce-delays/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/the-patent-trial-and-appeals-board-a-target-for-prescription-drug-patent-reform/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/patent-claim-scope-and-biosimilar-competition-in-the-us-and-eu/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/invited-commentary-on-interventional-pharmacoepidemiology-origins-current-status-and-future-possibilities/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/shortages-of-essential-generic-drugs-with-limited-competition/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/estimating-costs-in-beremagene-geperpavec-for-dystrophic-epidermolysis-bullosa-reply/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/estimated-savings-under-the-medicare-high-value-drug-list-model/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/comparing-supplemental-indications-for-cancer-drugs-approved-in-the-us-and-eu/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/testing-of-new-drugs-approved-from-2015-through-2021-under-the-us-pediatric-research-equity-act/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/does-policy-uncertainty-boost-vaccine-hesitancy-political-controversy-the-fda-and-covid-19-vaccine-hesitancy-in-fall-2020/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/us-food-and-drug-administrations-directive-to-deal-with-delayed-confirmatory-trials-lessons-from-pralatrexate-and-belinostat-for-t-cell-lymphoma/ 2026-03-06T16:37:41+00:00 https://portalresearch.org/portal_work/medicares-first-round-of-drug-price-negotiation-measuring-success/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/how-agencies-should-decide-which-costly-drugs-to-target-with-government-march-in-rights/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/strategies-to-help-patients-navigate-high-prescription-drug-costs/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/azithromycin-to-reduce-mortality/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/impact-of-priority-review-voucher-eligibility-on-research-and-development-of-medical-countermeasures/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/clinical-benefit-and-revenues-of-drugs-affected-by-rare-pediatric-disease-priority-review-vouchers-2017-2023/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/association-between-changes-in-prices-and-out%e2%80%90of%e2%80%90pocket-costs-for-brand%e2%80%90name-clinician%e2%80%90administered-drugs/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/multiple-myeloma-clinical-trials-exclude-patients-with-the-highest-risk-disease-a-systematic-review-of-trial-exclusion-criteria/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/the-long-con-an-empirical-analysis-of-pharmaceutical-patent-thickets/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/clearing-dense-drug-patent-thickets/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/will-the-new-administrations-fda-be-a-threat-or-an-opportunity-for-the-publics-health/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/use-spending-and-prices-of-adalimumab-following-biosimilar-competition/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/use-of-public-research-and-manufacturing-enterprises-to-lower-prescription-drug-prices-and-increase-innovation/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/characteristics-of-academic-inventors-on-government-linked-us-drug-patents/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/op-ed-lessons-from-humira-on-how-to-tackle-unjust-extensions-of-drug-monopolies-with-policy/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/differential-legal-protections-for-biologics-vs-small-molecule-drugs-in-the-us-2/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/comparative-effectiveness-and-safety-of-single-inhaler-triple-therapies-for-chronic-obstructive-pulmonary-disease-new-user-cohort-study/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/revising-eu-pharmaceutical-legislation-will-it-foster-drug-repurposing/ 2026-03-06T16:37:42+00:00 https://portalresearch.org/portal_work/pediatric-exclusivity-revenues-for-cancer-drugs/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/leveraging-old-hepatitis-c-therapies/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/accelerating-biosimilar-market-access-the-case-for-allowing-earlier-standing/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/academic-detailing-interventions-and-evidence-based-prescribing-a-systematic-review/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/the-role-of-importation-in-remediating-u-s-generic-drug-shortages/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/characteristics-of-trials-preceding-fda-approval-of-novel-psychiatric-drugs/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/op-ed-how-to-protect-hhs-fda-nih-and-other-health-agencies-from-political-interference/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/a-regulatory-roadmap-for-repurposing-comparing-pathways-for-making-repurposed-drugs-available-in-the-eu-uk-and-us/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/regulatory-flexibilities-balancing-unmet-needs-benefits-and-risks-in-the-approvals-of-imported-cancer-drugs-in-china-a-cohort-study-from-2012-to-2021/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/physician-patient-communication-about-novel-drugs-and-high-risk-medical-devices/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/government-funding-for-the-development-of-enzalutamide/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/ai-devices-in-neurology-moving-from-diagnosis-to-prognosis/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/financial-challenges-of-being-on-long-term-high-cost-medications/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/predicting-patent-challenges-for-small-molecule-drugs-a-cross-sectional-study/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/physician-experiences-with-and-perspectives-on-clozapine-prescribing/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/health-care-spending-after-initiating-sacubitril-valsartan-vs-renin-angiotensin-system-blockers-for-heart-failure-treatment/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/out-of-pocket-getting-out-of-hand-reducing-the-financial-toxicity-of-rapidly-approved-drugs/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/the-moral-injury-of-inhaler-prescribing/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/using-trademarks-to-ensure-completion-of-postapproval-trials/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/the-puzzle-of-biologics-manufacturing-platform-patents/ 2026-03-06T16:37:44+00:00 https://portalresearch.org/portal_work/out-of-pocket-savings-under-the-inhaler-price-cap/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/national-survey-of-factors-associated-with-physician-antibiotic-prescribing-preferences/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/first-in-class-drugs-experienced-different-regulatory-treatment-in-the-us-and-europe/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/changes-in-biologic-drug-revenues-after-administrative-patent-challenges/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/an-empirical-investigation-into-concerns-over-quality-adjusted-life-years-a-review-of-cost-effectiveness-analyses-in-oncology/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/real-world-evidence-is-a-vital-tool-for-informing-treatment-strategies-in-chronic-obstructive-pulmonary-disease/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/active-postmarketing-device-surveillance-as-a-legislative-priority/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/trends-in-fills-spending-and-prices-of-doxepin-for-insomnia/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/factors-in-time-to-full-approval-or-withdrawal-for-anticancer-medicines-granted-accelerated-approval-by-the-fda/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/will-i-feel-better-raising-the-bar-for-quality-of-life-in-oncology/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/glucose-lowering-medications-and-risk-of-chronic-obstructive-pulmonary-disease-exacerbations-in-patients-with-type-2-diabetes/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/frequency-of-first-generic-drugs-approved-through-skinny-labeling-2021-to-2023/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/comparative-bleeding-risk-in-older-patients-with-hiv-and-atrial-fibrillation-receiving-oral-anticoagulants/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/therapeutic-benefit-of-top-selling-oncology-drugs-in-medicare/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/patent-thickets-and-product-hops-challenges-and-opportunities-for-legislative-reform/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/engaging-pharmacists-in-strategies-for-navigating-prescription-drug-costs-reply/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/op-ed-its-not-hard-to-see-through-rfk-jr-s-radical-transparency-pledge/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/certification-marks-for-supporting-generic-drug-quality/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/sotorasibs-accelerated-approval-wrong-dose-and-indication/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/primary-medication-adherence-in-medicare-beneficiaries-prescribed-sacubitril-valsartan-or-renin-angiotensin-system-blockers-for-heart-failure-with-reduced-ejection-fraction/ 2026-03-06T16:37:46+00:00 https://portalresearch.org/portal_work/opioid-settlements-in-canada-avoiding-u-s-pitfalls-embracing-best-practices/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/strategies-to-advance-drug-repurposing-for-rare-diseases/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/drug-versioning-and-legal-accountability-for-preventable-product-harms/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/costs-of-extending-the-small-molecule-exemption-period-in-medicare-drug-price-negotiation/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/the-comparative-effectiveness-and-safety-of-fluticasone-salmeterol-via-metered-dose-versus-dry-powder-inhalers-for-copd-a-new-user-cohort-study/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/op-ed-the-trouble-with-do-your-own-research-for-drugs/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/use-and-cost-of-first-line-biologic-medications-to-treat-plaque-psoriasis-in-the-us/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/predictors-of-withdrawal-of-anticancer-drug-indications-granted-accelerated-approval-a-retrospective-cohort-study/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/changes-in-oncology-medication-use-after-withdrawal-of-accelerated-approval/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/association-between-industry-payments-and-prescription-of-inhaled-medications/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/medicare-spending-and-use-of-subcutaneous-biologic-formulations-with-hyaluronidase/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/what-can-we-learn-from-patient-input-at-fda-advisory-committee-meetings/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/disappearing-data-at-the-u-s-federal-government/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/congress-should-remove-the-rare-disease-carve-out-from-medicare-drug-price-negotiation-not-expand-it/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/examining-pricing-and-availability-for-neglected-tropical-disease-therapies-in-the-united-states/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/the-strength-and-importance-of-government-funded-patents-for-approved-drugs/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/frequency-and-nature-of-generic-design-around-of-brand%e2%80%90name-patents-in-the-united-states/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/evolving-recommendations-for-patient-populations-among-oncology-medicines-a-quantitative-and-qualitative-analysis/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/design-patents-a-potential-threat-to-drug-competition/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/data-manipulation-within-the-us-federal-government/ 2026-03-06T16:37:47+00:00 https://portalresearch.org/portal_work/trumps-ongoing-tariff-chaos-will-make-medications-less-affordable-and-harder-to-find/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/impostor-syndrome-fraudulent-participants-in-qualitative-research-can-skew-results/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/revenue-patents-and-new-generic-competition-for-prescription-drugs-in-the-usa/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/prescription-drug-method-of-use-patent-protection-1991-2018/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/insurer-exits-after-the-inflation-reduction-act-part-d-redesign/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/the-puzzle-of-biologics-manufacturing-platform-patents-reply/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/health-technology-assessment-again-a-transparent-evidence-based-approach-for-cms-drug-price-negotiations/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/expansion-of-340b-disproportionate-share-hospitals-in-the-united-states-from-2010-to-2022/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/differences-between-trial-populations-and-approved-label-populations-of-new-drugs-in-the-united-states-and-europe-2012-to-2023-a-cross-sectional-study/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/community-pharmacy-turnover-and-context-of-openings-and-closings-by-ownership-type/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/the-limits-of-physician-level-interventions-for-cost-related-nonadherence-a-case-for-structural-reform/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/combating-pharmaceutical-patent-thickets-in-the-trump-administration/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/drug-versioning-and-legal-accountability-reply/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/benefits-and-limitations-of-direct-to-consumer-pharmacies-in-the-us/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/health-professional-students-knowledge-about-fda-drug-and-medical-device-regulation/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/estimating-costs-of-market-exclusivity-extensions-for-4-top-selling-prescription-drugs-in-the-us/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/the-advisory-committee-on-immunization-practices-legal-roles-challenges-and-guardrails/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/advance-market-commitments-and-their-role-in-public-innovation/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/trends-in-time-to-withdrawal-and-full-approval-of-accelerated-approval-cancer-drug-indications-1992-2024/ 2026-03-06T16:37:49+00:00 https://portalresearch.org/portal_work/pediatric-exclusivity-associated-revenues-and-labeling-changes-2013-2023/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/national-analysis-of-the-requirements-and-implementation-of-state-prescription-drug-price-transparency-laws/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/lowering-drug-prices-in-the-us-look-within-not-abroad/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/physician-perspectives-on-pharmaceutical-promotion/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/medicare-part-d-savings-under-the-manufacturer-discount-program-vs-coverage-gap-discounts/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/bridging-the-fair-share-gap-for-antibacterial-innovation-an-observational-analysis-of-antibacterial-revenues-in-the-g7-and-eu27/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/breakthrough-therapy-designations-in-china-and-the-united-states/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/overlapping-method-of-use-patents-to-prevent-generic-entry/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/modeling-the-budgetary-impacts-of-sickle-cell-disease-gene-therapies-on-state-medicaid-programs/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/fda-regulatory-pathways-for-expedited-drug-development-and-approval/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/prices-and-spending-for-phosphodiesterase-4-inhibitors-in-pulmonary-and-dermatologic-disease/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/whose-burden-whose-benefit-revisiting-ethical-trade-offs-in-the-who-guidelines-on-scaling-up-mass-azithromycin-administration/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/isotretinoin-risk-evaluation-and-mitigation-strategy-and-pregnancy-incidence/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/changes-in-medicare-part-d-plan-designs-after-the-inflation-reduction-act/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/regulatory-and-clinical-outcomes-of-nononcology-accelerated-approvals/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/trends-in-medicare-spending-on-drugs-for-pulmonary-arterial-hypertension-2012-2022/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/pharmaceutical-access-in-brazil-challenges-and-opportunities/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/revenue-differences-between-top-selling-small-molecule-drugs-and-biologics-in-medicare/ 2026-03-06T16:37:51+00:00 https://portalresearch.org/portal_work/role-of-health-workers-and-representative-health-worker-organisations-in-lmic-pharmaceutical-policy-a-scoping-review-protocol/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/op-ed-corporate-support-cannot-make-up-for-threats-to-the-nih-budget-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/flaws-in-the-fdas-new-priority-voucher-program/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/halting-hyaluronidase-hopping-to-maintain-the-integrity-of-medicare-drug-price-negotiation-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/glucagon-like-peptide-1-receptor-agonists-and-pay-per-click-direct-to-consumer-advertising/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/us-government-spending-on-new-drugs-with-incomplete-and-postponed-mandatory-pediatric-trials/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/recent-changes-in-discretionary-denials-of-drug-patent-challenges-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/therapeutic-value-and-regulatory-characteristics-of-breakthrough-therapy-drugs-in-the-usa-and-china-2021-2023-a-retrospective-cohort-study-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/real-world-evidence-in-drug-approvals-at-the-european-medicines-agency-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/pricing-trends-and-overlapping-indications-of-checkpoint-inhibitors-for-cancer-treatment-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/patient-and-population-impacts-of-multigene-panel-and-pembrolizumab-coverage-in-metastatic-melanoma-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/optimizing-oncology-drug-development-systematic-review-of-22-years-of-myeloma-randomized-controlled-trials/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/inhaler-related-greenhouse-gas-emissions-in-the-us-a-serial-cross-sectional-analysis-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/enhancing-formulary-accessibility-a-step-toward-better-care-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/us-spending-on-high-revenue-rare-disease-drugs-in-2022-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/mapping-intellectual-property-abuses-in-the-pharmaceutical-field-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/op-ed-the-trump-administration-is-turning-drug-review-into-make-a-deal/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/prescription-drugs-subject-to-a-risk-evaluation-and-mitigation-strategy-patient-perspectives-on-risk-communication-and-the-value-of-educational-materials-2/ 2026-03-06T16:37:52+00:00 https://portalresearch.org/portal_work/constructing-opioid-legitimacy-the-canadian-pain-task-forces-framing-of-the-overdose-crisis/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/the-strength-and-importance-of-government-funded-patents-for-approved-drugs-reply-2/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/discovering-a-transformative-cancer-drug-the-case-of-ibrutinib-2/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/serial-patent-litigation-an-emerging-strategy-to-delay-entry-of-generic-competition-2/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/outcomes-of-nononcology-accelerated-approvals-reply-2/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/the-pharmaceutical-industrys-quiet-win-in-the-one-big-beautiful-bill-act-2/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/estimating-racial-and-ethnic-disparities-in-substance-use-disorder-treatment-and-harm-reduction-services-findings-from-a-survey-of-people-who-use-drugs-2/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/characteristics-of-speakers-at-us-fda-advisory-committee-meetings-on-drug-approval/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/stigma-scarcity-and-the-price-of-legitimacy-chronic-pain-advocacy-and-the-politics-of-pharmaceutical-partnerships-in-canada/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/tertiary-patents-on-drugs-approved-by-the-fda/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/changes-in-medication-use-during-medicaid-continuous-enrollment-and-unwinding-2/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/combination-only-approvals-as-a-barrier-to-affordable-hiv-care/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/out-of-pocket-spending-for-biologic-drugs-after-biosimilar-competition-for-medicare-patients/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/physician-perspectives-on-real-world-evidence-for-prescribing-to-older-patients/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/tumultuous-development-of-venetoclax-in-t1114-multiple-myeloma/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/physician-awareness-of-fdas-relaxation-of-rems-required-laboratory-testing-requirements-and-changes-in-prescribing-practices-during-the-covid-19-pandemic/ 2026-03-06T16:37:54+00:00 https://portalresearch.org/portal_work/regulating-laboratory-tests-what-framework-would-best-support-safety-and-validity/ 2026-03-06T17:36:16+00:00 https://portalresearch.org/portal_work/fireproofing-the-fda-power-politics-and-public-health/ 2026-03-06T17:38:42+00:00 https://portalresearch.org/portal_work/a-comparative-analysis-of-international-drug-price-negotiation-frameworks-an-interview-study-of-key-stakeholders/ 2026-03-06T17:45:07+00:00 https://portalresearch.org/portal_work/university-based-science-and-biotechnology-products-defining-the-boundaries-of-intellectual-property/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/the-rise-and-fall-of-natrecor-for-congestive-heart-failure-implications-for-drug-policy/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/extensions-of-intellectual-property-rights-and-delayed-adoption-of-generic-drugs-effects-on-medicaid-spending/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/confidentiality-laws-and-secrecy-in-medical-research-improving-public-access-to-data-on-drug-safety/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/intellectual-property-policy-in-the-pharmaceutical-sciences-the-effect-of-inappropriate-patents-and-market-exclusivity-extensions-on-the-health-care-system/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/the-variability-and-quality-of-medication-container-labels/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/the-international-pharmaceutical-market-as-a-source-of-low-cost-prescription-drugs-for-u-s-patients/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/pharmaceutical-promotion-to-physicians-and-first-amendment-rights/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/think-globally-prescribe-locally-how-rational-pharmaceutical-policy-in-the-u-s-can-improve-global-access-to-essential-medicines/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/whistleblower-initiated-enforcement-actions-against-health-care-fraud-and-abuse-in-the-united-states-1996-to-2005/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/drug-development-for-neglected-diseases-the-trouble-with-fda-review-vouchers/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/clinical-equivalence-of-generic-and-brand-name-drugs-used-in-cardiovascular-disease-a-systematic-review-and-meta-analysis/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/how-medicare-could-get-better-prices-on-prescription-drugs/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/seizure-outcomes-following-the-use-of-generic-versus-brand-name-antiepileptic-drugs-a-systematic-review-and-meta-analysis/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/whistle-blowers-experiences-in-fraud-litigation-against-pharmaceutical-companies/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/state-generic-substitution-laws-can-lower-drug-outlays-under-medicaid/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/managing-financial-and-nonfinancial-conflicts-of-interest-in-healthcare-delivery/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/fighting-antibiotic-resistance-marrying-new-financial-incentives-to-meeting-public-health-goals/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/using-market-exclusivity-incentives-to-promote-pharmaceutical-innovation/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/where-cost-medical-necessity-and-morality-meet-should-us-government-insurance-programs-pay-for-erectile-dysfunction-drugs/ 2026-03-15T14:42:33+00:00 https://portalresearch.org/portal_work/who-owns-federally-funded-research-the-supreme-court-and-the-bayh-dole-act/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/the-nih-translational-research-center-might-trade-public-risk-for-private-reward/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/conflict-of-interest-in-oncology-publications-a-survey-of-disclosure-policies-and-statements/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/the-prevalence-and-cost-of-unapproved-uses-of-top-selling-orphan-drugs/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/ethical-issues-in-new-drug-prescribing/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/ethical-considerations-in-orphan-drug-approval-and-use/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/conflict-of-interest-reporting-by-authors-involved-in-promotion-of-off-label-drug-use-an-analysis-of-journal-disclosures/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/the-food-and-drug-administration-has-the-legal-basis-to-restrict-promotion-of-flawed-comparative-effectiveness-research/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/an-exploration-of-compulsory-licensing-as-an-effective-policy-tool-for-antiretroviral-drugs-in-india/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/variations-in-pill-appearance-of-antiepileptic-drugs-and-the-risk-of-nonadherence/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/the-most-transformative-drugs-of-the-past-25-years-a-survey-of-physicians/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/changing-interactions-between-physician-trainees-and-the-pharmaceutical-industry-a-national-survey/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/speaking-the-same-language-international-variations-in-the-safety-information-accompanying-top-selling-prescription-drugs/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/pharmaceutical-efficacy-the-illusory-legal-standard/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/ethical-and-legal-views-regarding-deactivation-of-cardiac-implantable-electrical-devices-in-patients-with-hypertrophic-cardiomyopathy/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/safety-supply-and-suits-litigation-and-the-vaccine-industry/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/medical-students-exposure-to-and-attitudes-about-the-pharmaceutical-industry-a-systematic-review/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/characteristics-of-clinical-trials-to-support-approval-of-orphan-vs-nonorphan-drugs-for-cancer/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/why-do-the-same-drugs-look-different-pills-trade-dress-and-public-health/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/an-empirical-review-of-major-legislation-affecting-drug-development-past-experiences-effects-and-unintended-consequences/ 2026-03-15T14:42:34+00:00 https://portalresearch.org/portal_work/defining-innovativeness-in-drug-development-a-systematic-review/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/institutional-corruption-of-pharmaceuticals-and-the-myth-of-safe-and-effective-drugs/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/the-role-of-direct-to-consumer-pharmaceutical-advertising-in-patient-consumerism/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/clinical-and-regulatory-features-of-drugs-not-initially-approved-by-the-fda/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/life-cycle-of-medical-product-rules-issued-by-the-us-food-and-drug-administration/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/ensuring-medical-device-effectiveness-and-safety-a-cross-national-comparison-of-approaches-to-regulation/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/fda-approval-of-cardiac-implantable-electronic-devices-via-original-and-supplement-premarket-approval-pathways-1979-2012/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/quantifying-the-food-and-drug-administrations-rulemaking-delays-highlights-the-need-for-transparency/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/clinicians-contributions-to-the-development-of-coronary-artery-stents-a-qualitative-study-of-transformative-device-innovation/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/strategies-for-postmarketing-surveillance-of-drugs-for-rare-diseases/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/assessing-the-chiral-switch-approval-and-use-of-single-enantiomer-drugs-2001-to-2011/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/postmarketing-trials-and-pediatric-device-approvals/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/restrictions-on-pharmaceutical-detailing-reduced-off-label-prescribing-of-antidepressants-and-antipsychotics-in-children/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/prospects-for-regulation-of-off-label-promotion-in-an-era-of-expanding-commercial-speech-protection/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/evidence-errors-and-ethics/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/approval-of-high-risk-medical-devices-in-the-us-implications-for-clinical-cardiology/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/association-of-marketing-interactions-with-medical-trainees-knowledge-about-evidence-based-prescribing-results-from-a-national-survey/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/comparative-effectiveness-of-generic-and-brand-name-statins-on-patient-outcomes-a-cohort-study/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/electronic-medication-packaging-devices-and-medication-adherence-a-systematic-review/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/association-of-medical-students-reports-of-interactions-with-the-pharmaceutical-and-medical-device-industries-and-medical-school-policies-and-characteristics-a-cross-sectional-study/ 2026-03-15T14:42:36+00:00 https://portalresearch.org/portal_work/innovative-research-methods-for-studying-treatments-for-rare-diseases-methodological-review/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/fda-designations-for-therapeutics-and-their-impact-on-drug-development-and-regulatory-review-outcomes/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/the-roles-of-academia-rare-diseases-and-repurposing-in-the-development-of-the-most-transformative-drugs/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/prescription-drug-insurance-coverage-and-patient-health-outcomes-a-systematic-review/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/development-and-use-of-new-therapeutics-for-rare-diseases-views-from-patients-caregivers-and-advocates/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/are-risk-evaluation-and-mitigation-strategies-associated-with-less-off-label-use-of-medications-the-case-of-immune-thrombocytopenia/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/a-cross%e2%80%90national-comparison-of-17-countries-insulin-glargine-drug-labels/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/mandatory-disclaimers-on-dietary-supplements-do-not-reliably-communicate-the-intended-issues/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/availability-and-utilization-of-cardiovascular-fixed-dose-combination-drugs-in-the-united-states/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/hatch-waxman-turns-30-do-we-need-a-re-designed-approach-for-the-modern-era/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/characteristics-of-efficacy-evidence-supporting-approval-of-supplemental-indications-for-prescription-drugs-in-united-states-2005-14-systematic-review/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/trends-in-medicaid-reimbursements-for-insulin-from-1991-through-2014/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/reductions-in-use-of-colchicine-after-fda-enforcement-of-market-exclusivity-in-a-commercially-insured-population/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/comparative-effectiveness-of-generic-versus-brand-name-antiepileptic-medications/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/physicians-and-insider-trading/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/medical-schools-industry-interaction-policies-not-associated-with-trainees-self-reported-behavior-as-residents-results-of-a-national-survey/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/do-march%e2%80%90in-rights-ensure-access-to-medical-products-arising-from-federally-funded-research-a-qualitative-study/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/benefit-risk-and-outcomes-in-drug-development-a-systematic-review-of-sunitinib/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/vaccine-pipeline-has-grown-during-the-past-two-decades-with-more-early-stage-trials-from-small-and-medium-size-companies/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/key-features-of-academic-detailing-development-of-an-expert-consensus-using-the-delphi-method/ 2026-03-15T14:42:38+00:00 https://portalresearch.org/portal_work/did-fda-decisionmaking-affect-anti-psychotic-drug-prescribing-in-children-a-time-trend-analysis/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/drug-product-life-cycle-management-as-anticompetitive-behavior-the-case-of-memantine/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/leveraging-novel-and-existing-pathways-to-approve-new-therapeutics-to-treat-serious-drug-resistant-infections/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/government-patent-use-a-legal-approach-to-reducing-drug-spending/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/utilization-of-the-first-biosimilar-infliximab-since-its-approval-in-south-korea/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/variations-in-patients-perceptions-and-use-of-generic-drugs-results-of-a-national-survey/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/association-of-industry-payments-to-physicians-with-the-prescribing-of-brand-name-statins-in-massachusetts/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/anti-vegf-therapy-in-ophthalmology-a-qualitative-analysis-of-transformative-drug-development/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/using-antitrust-law-to-challenge-turings-daraprim-price-increase/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/comparison-of-rates-of-safety-issues-and-reporting-of-trial-outcomes-for-medical-devices-approved-in-the-european-union-and-united-states-cohort-study/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/protecting-pharmaceutical-patents-and-test-data-how-the-trans-pacific-partnership-agreement-could-affect-access-to-medicines-in-the-us-and-abroad/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/temporal-trends-and-factors-associated-with-cardiovascular-drug-development-1990-to-2012/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/switch-backs-associated-with-generic-drugs-approved-using-product-specific-determinations-of-therapeutic-equivalence-generics-approved-by-product-specific-approaches/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/effect-of-generic-competition-on-atorvastatin-prescribing-and-patients-out-of-pocket-spending/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/progress-in-the-fight-against-multidrug-resistant-bacteria-a-review-of-u-s-food-and-drug-administration-approved-antibiotics-2010-2015/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/physicians-trust-in-the-fdas-use-of-product-specific-pathways-for-generic-drug-approval/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/switching-generic-antiepileptic-drug-manufacturer-not-linked-to-seizures-a-case-crossover-study/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/regulatory-incentives-for-antibiotic-drug-development-a-review-of-recent-proposals/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/failure-of-investigational-drugs-in-late-stage-clinical-development-and-publication-of-trial-results/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/comparative-effectiveness-and-safety-of-thalidomide-and-lenalidomide-in-patients-with-multiple-myeloma-in-the-united-states-of-america-a-population-based-cohort-study/ 2026-03-15T14:42:39+00:00 https://portalresearch.org/portal_work/six-month-market-exclusivity-extensions-to-promote-research-offer-substantial-returns-for-many-drug-makers/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/clinical-evidence-supporting-us-food-and-drug-administration-premarket-approval-of-high%e2%80%90risk-otolaryngologic-devices-2000%e2%80%902014/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/outcomes-associated-with-generic-drugs-approved-using-product-specific-determinations-of-therapeutic-equivalence/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/clinical-evidence-supporting-us-food-and-drug-administration-approval-of-otolaryngologic-prescription-drug-indications-2005%e2%80%902014/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/the-effect-of-federal-and-state-off-label-marketing-investigations-on-drug-prescribing-the-case-of-olanzapine/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/media-coverage-of-fda-drug-safety-communications-about-zolpidem-a-quantitative-and-qualitative-analysis/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/success-failure-and-transparency-in-biomarker-based-drug-development-a-case-study-of-cholesteryl-ester-transfer-protein-inhibitors/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/patient-and-physician-perceptions-of-drug-safety-information-for-sleep-aids-a-qualitative-study/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/do-patients-trust-the-fda-a-survey-assessing-how-patients-view-the-generic-drug-approval-process/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/changes-in-prescribing-and-healthcare-resource-utilization-after-fda-drug-safety-communications-involving-zolpidem-containing-medications-prescribing-after-drug-safety-communications/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/high-generic-drug-prices-and-market-competition-a-retrospective-cohort-study/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/effect-of-us-food-and-drug-administrations-cardiovascular-safety-guidance-on-diabetes-drug-development/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/characteristics-of-preapproval-and-postapproval-studies-for-drugs-granted-accelerated-approval-by-the-us-food-and-drug-administration/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/influence-integrity-and-the-fda-an-ethical-framework/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/safety-related-label-changes-for-new-drugs-after-approval-in-the-us-through-expedited-regulatory-pathways-retrospective-cohort-study/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/outcomes-based-pharmaceutical-contracts-an-answer-to-high-u-s-drug-spending/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/the-real%e2%80%90world-ethics-of-adaptive%e2%80%90design-clinical-trials/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/strategies-that-delay-market-entry-of-generic-drugs/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/determinants-of-market-exclusivity-for-prescription-drugs-in-the-united-states/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/trends-in-pricing-and-generic-competition-within-the-oral-antibiotic-drug-market-in-the-united-states/ 2026-03-15T14:42:41+00:00 https://portalresearch.org/portal_work/use-of-health-care-databases-to-support-supplemental-indications-of-approved-medications/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/social-media-impact-of-the-food-and-drug-administrations-drug-safety-communication-messaging-about-zolpidem-mixed-methods-analysis/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/adaptive-design-clinical-trials-a-review-of-the-literature-and-clinicaltrials-gov/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/delays-in-completion-and-results-reporting-of-clinical-trials-under-the-pediatric-regulation-in-the-european-union-a-cohort-study/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/affordability-and-availability-of-off-patent-drugs-in-the-united-states-the-case-for-importing-from-abroad-observational-study/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/affordability-and-price-increases-of-new-cancer-drugs-in-clinical-guidelines-2007-2016/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/differences-in-rates-of-switchbacks-after-switching-from-branded-to-authorized-generic-and-branded-to-generic-drug-products-cohort-study/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/precision-medicines-have-faster-approvals-based-on-fewer-and-smaller-trials-than-other-medicines/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/evaluating-the-impact-of-the-orphan-drug-acts-seven-year-market-exclusivity-period/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/application-and-impact-of-run-in-studies/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/towards-a-global-definition-of-responsible-antibiotic-use-results-of-an-international-multidisciplinary-consensus-procedure/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/quality-indicators-for-responsible-antibiotic-use-in-the-inpatient-setting-a-systematic-review-followed-by-an-international-multidisciplinary-consensus-procedure/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/metrics-for-quantifying-antibiotic-use-in-the-hospital-setting-results-from-a-systematic-review-and-international-multidisciplinary-consensus-procedure/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/generic-versions-of-narrow-therapeutic-index-drugs-a-national-survey-of-pharmacists-substitution-beliefs-and-practices/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/efficacy-safety-and-regulatory-approval-of-food-and-drug-administration-designated-breakthrough-and-nonbreakthrough-cancer-medicines/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/a-comparison-of-response-patterns-for-progression-free-survival-and-overall-survival-following-treatment-for-cancer-with-pd-1-inhibitors-a-meta-analysis-of-correlation-and-differences-in-effect-sizes/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/implementing-a-public-health-perspective-in-fda-drug-regulation/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/medicare-spending-on-brand-name-combination-medications-vs-their-generic-constituents/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/when-markets-fail-patents-and-infectious-disease-products/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/a-systematic-review-of-the-food-and-drug-administrations-exception-from-informed-consent-pathway/ 2026-03-15T14:42:43+00:00 https://portalresearch.org/portal_work/duration-of-adjuvant-immunotherapy-biologic-clinical-and-economic-considerations/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/labeling-changes-and-costs-for-clinical-trials-performed-under-the-us-food-and-drug-administration-pediatric-exclusivity-extension-2007-to-2012/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/changes-in-outpatient-use-of-antibiotics-by-adults-in-the-united-states-2006-2015/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/a-method-for-approximating-future-entry-of-generic-drugs/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/the-us-biosimilar-market-stunted-growth-and-possible-reforms/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/patent-term-restoration-for-top-selling-drugs-in-the-united-states/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/effect-of-lawyer-submitted-reports-on-signals-of-disproportional-reporting-in-the-food-and-drug-administrations-adverse-event-reporting-system/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/completion-rate-and-reporting-of-mandatory-pediatric-postmarketing-studies-under-the-us-pediatric-research-equity-act/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/a-systematic-review-of-trial-level-meta-analyses-measuring-the-strength-of-association-between-surrogate-end-points-and-overall-survival-in-oncology/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/patient-centered-cancer-drug-development-clinical-trials-regulatory-approval-and-value-assessment/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/implementation-of-a-health-plan-program-for-switching-from-analogue-to-human-insulin-and-glycemic-control-among-medicare-beneficiaries-with-type-2-diabetes/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/the-generic-drug-industry-embraces-a-faster-cheaper-pathway-for-challenging-patents/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/new-drug-formulations-and-their-respective-generic-entry-dates/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/impact-of-the-priority-review-voucher-program-on-drug-development-for-rare-pediatric-diseases/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/assessment-of-use-of-combined-dextromethorphan-and-quinidine-in-patients-with-dementia-or-parkinson-disease-after-us-food-and-drug-administration-approval-for-pseudobulbar-affect/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/analysis-of-proposed-medicare-part-b-to-part-d-shift-with-associated-changes-in-total-spending-and-patient-cost-sharing-for-prescription-drugs/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/a-survey-of-patients-perceptions-of-pill-appearance-and-responses-to-changes-in-appearance-for-four-chronic-disease-medications/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/comparative-effectiveness-of-generic-and-brand-name-medication-use-a-database-study-of-us-health-insurance-claims/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/association-between-progression-free-survival-and-patients-quality-of-life-in-cancer-clinical-trials/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/assessment-of-the-role-of-niacin-in-managing-cardiovascular-disease-outcomes-a-systematic-review-and-meta-analysis/ 2026-03-15T14:42:45+00:00 https://portalresearch.org/portal_work/evaluation-of-socioeconomic-status-indicators-for-confounding-adjustment-in-observational-studies-of-medication-use/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/landscape-of-cardiovascular-device-registries-in-the-united-states/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/the-impact-of-price-regulation-on-the-availability-of-new-drugs-in-germany/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/spending-on-world-health-organization-essential-medicines-in-medicare-part-d-2011-15-retrospective-cost-analysis/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/competition-and-price-among-brand-name-drugs-in-the-same-class-a-systematic-review-of-the-evidence/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/characteristics-of-trials-and-regulatory-pathways-leading-to-us-approval-of-innovative-vs-non-innovative-oncology-drugs/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/assessing-the-justification-funding-success-and-survival-outcomes-of-randomized-noninferiority-trials-of-cancer-drugs-a-systematic-review-and-pooled-analysis/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/design-characteristics-risk-of-bias-and-reporting-of-randomised-controlled-trials-supporting-approvals-of-cancer-drugs-by-european-medicines-agency-2014-16-cross-sectional-analysis/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/patients-knowledge-of-key-messaging-in-drug-safety-communications-for-zolpidem-and-eszopiclone-a-national-survey/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/application-of-orphan-drug-designation-to-cancer-treatments-2008-2017-a-comprehensive-and-comparative-analysis-of-the-usa-and-eu/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/desmopressin-and-the-risk-of-hyponatremia-a-population-based-cohort-study/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/public-sector-financial-support-for-late-stage-discovery-of-new-drugs-in-the-united-states-cohort-study/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/randomized-study-of-providing-evidence-context-to-mitigate-physician-misinterpretation-arising-from-off-label-drug-promotion/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/physician-perceptions-of-step-therapy-prescribing-requirements/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/variation-in-prescription-drug-prices-by-retail-pharmacy-type-a-national-cross-sectional-study/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/prescription-opioid-epidemic-and-trends-in-the-clinical-development-of-new-pain-medications/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/expanding-coverage-of-oncology-drugs-in-an-aging-upper-middle-income-country-analyses-of-public-and-private-expenditures-in-chile/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/us-food-and-drug-administration-recommendations-on-the-use-of-surrogate-measures-as-end-points-in-new-anti-infective-drug-approvals/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/response-rates-and-durations-of-response-for-biomarker-based-cancer-drugs-in-nonrandomized-versus-randomized-trials/ 2026-03-15T14:42:46+00:00 https://portalresearch.org/portal_work/incentivizing-antibiotic-development-why-isnt-the-generating-antibiotic-incentives-now-gain-act-working/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/confidentiality-orders-and-public-interest-in-drug-and-medical-device-litigation/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/generating-comparative-evidence-on-new-drugs-and-devices-before-approval/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/prescribing-systemic-steroids-for-acute-respiratory-tract-infections-in-united-states-outpatient-settings-a-nationwide-population-based-cohort-study/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/using-data-from-routine-care-to-estimate-the-effectiveness-and-potential-limitations-of-outcomes-based-contracts-for-diabetes-medications/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/a-systematic-review-and-meta-analysis-of-bevacizumab-in-first-line-metastatic-breast-cancer-lessons-for-research-and-regulatory-enterprises/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/prices-and-clinical-benefit-of-cancer-drugs-in-the-usa-and-europe-a-cost-benefit-analysis/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/estimating-the-cost-of-delayed-generic-drug-entry-to-medicaid/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/comparative-outcomes-of-treatment-initiation-with-brand-vs-generic-warfarin-in-older-patients/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/reconsidering-the-scope-of-us-state-laws-allowing-pharmacist-substitution-of-generic-drugs/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/regulatory-approval-characteristics-of-antimicrobial-versus-non-antimicrobial-products-1984-2018-an-evaluation-of-food-and-drug-administration-flexibilities/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/lessons-from-the-impact-of-price-regulation-on-the-pricing-of-anticancer-drugs-in-germany/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/us-spending-associated-with-transition-from-daily-to-3-times-weekly-glatiramer-acetate/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/projected-spending-for-brand-name-drugs-in-english-primary-care-given-us-prices-a-cross-sectional-study/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/understanding-when-real-world-data-can-be-used-to-replicate-a-clinical-trial-a-cross%e2%80%90sectional-study-of-medications-approved-in-2011/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/reputation-and-authority-the-fda-and-the-fight-over-u-s-prescription-drug-importation/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/clinical-development-times-for-biosimilars-in-the-united-states/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/clinical-benefit-and-cost-of-breakthrough-cancer-drugs-approved-by-the-us-food-and-drug-administration/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/association-between-fda-and-ema-expedited-approval-programs-and-therapeutic-value-of-new-medicines-retrospective-cohort-study/ 2026-03-15T14:42:48+00:00 https://portalresearch.org/portal_work/heterogeneity-of-antidiabetic-treatment-effect-on-the-risk-of-major-adverse-cardiovascular-events-in-type-2-diabetes-a-systematic-review-and-meta-analysis/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/comparing-onset-of-biosimilar-versus-generic-competition-in-the-united-states/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/public-funding-for-transformative-drugs-the-case-of-sofosbuvir/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/assessment-of-variation-in-state-regulation-of-generic-drug-and-interchangeable-biologic-substitutions/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/an-overview-of-vaccine-development-approval-and-regulation-with-implications-for-covid-19/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/repurposing-existing-drugs-for-new-uses-a-cohort-study-of-the-frequency-of-fda-granted-new-indication-exclusivities-since-1997/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/market-exclusivity-length-for-drugs-with-new-generic-or-biosimilar-competition-2012-2018/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/factors-affecting-buprenorphine-utilization-and-spending-in-medicaid-2002-2018/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/buprenorphine-for-opioid-use-disorder-the-role-of-public-funding-in-its-development/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/a-correlation-analysis-to-assess-event-free-survival-as-a-trial-level-surrogate-for-overall-survival-in-early-breast-cancer/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/why-france-spends-less-than-the-united-states-on-drugs-a-comparative-study-of-drug-pricing-and-pricing-regulation/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/non-warfarin-oral-anticoagulant-copayments-and-adherence-in-atrial-fibrillation-a-population-based-cohort-study/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/changes-in-erythropoiesis-stimulating-agent-use-under-a-risk-evaluation-and-mitigation-strategy-rems-program/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/associations-between-copays-coverage-limits-for-opioid-use-disorder-medications-and-prescribing-in-medicaid-2018/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/international-reference-pricing-for-prescription-drugs-in-the-united-states-administrative-limitations-and-collateral-effects/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/assessment-of-coverage-in-england-of-cancer-drugs-qualifying-for-us-food-and-drug-administration-accelerated-approval/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/frequency-of-generic-drug-price-spikes-and-impact-on-medicaid-spending/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/diabetes-drugs-list-price-increases-were-not-always-reflected-in-net-price-impact-of-brand-competition-unclear/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/correlation-between-changes-in-brand-name-drug-prices-and-patient-out-of-pocket-costs/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/prospects-for-enforcing-prohibitions-on-off-label-drug-promotion-after-united-states-v-caronia-an-analysis-of-litigated-cases/ 2026-03-15T14:42:50+00:00 https://portalresearch.org/portal_work/postmarket-safety-communication-for-protection-of-public-health-a-comparison-of-regulatory-policy-in-australia-canada-the-european-union-and-the-united-states/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/factors-associated-with-generic-drug-uptake-in-the-united-states-2012-to-2017/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/caap-rule-and-prescription-drug-prices/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/barriers-to-us-biosimilar-market-growth-lessons-from-biosimilar-patent-litigation/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/fda-regulation-and-approval-of-medical-devices-1976-2020/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/mitigating-bias-in-machine-learning-for-medicine/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/the-timing-of-30-month-stay-expirations-and-generic-entry-a-cohort-study-of-first-generics-2013-2020/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/reimagining-pharmaceutical-market-exclusivities-should-the-duration-of-guaranteed-monopoly-periods-be-value-based/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/international-reference-pricing-for-prescription-drugs-a-landscape-analysis/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/how-should-clinicians-and-organizations-assess-risks-and-benefits-of-first-in-human-implantation-of-investigational-devices/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/controversy-over-using-quality-adjusted-life-years-in-cost-effectiveness-analyses-a-systematic-literature-review/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/regulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/analysis-of-launch-and-postapproval-cancer-drug-pricing-clinical-benefit-and-policy-implications-in-the-us-and-europe/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/cost-to-medicare-of-delayed-adalimumab-biosimilar-availability/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/assessing-the-impact-of-us-food-and-drug-administration-breakthrough-therapy-designation-timing-on-trial-characteristics-and-development-speed/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/influenza-vaccine-uptake-in-the-year-after-concurrent-vs-separate-influenza-and-zoster-immunization/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/states-preemption-and-patented-drug-prices/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/pursuing-value-based-prices-for-drugs-a-comprehensive-comparison-of-state-prescription-drug-pricing-boards/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/patient-and-payer-incentives-to-use-patented-brand-name-drugs-vs-authorized-generic-drugs-in-medicare-part-d/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/a-global-intellectual-property-waiver-is-still-needed-to-address-the-inequities-of-covid-19-and-future-pandemic-preparedness/ 2026-03-15T14:42:52+00:00 https://portalresearch.org/portal_work/associations-between-copays-coverage-limits-for-naloxone-and-prescribing-in-medicaid/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/differences-in-diabetic-prescription-drug-utilization-and-costs-among-patients-with-diabetes-enrolled-in-colorado-marketplace-and-medicaid-plans-2014-2015/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/premarket-development-times-for-innovative-vaccines-to-what-extent-are-the-coronavirus-disease-2019-covid-19-vaccines-outliers/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/regulatory-authority-and-clinical-acceptability-physicians-responses-to-regulatory-drug-safety-warnings/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/anticipated-efficiencies-real-costs-medicaid-managed-care-organizations-and-the-pharmacy-benefit/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/influence-of-drug-safety-advisories-on-drug-utilisation-an-international-interrupted-time-series-and-meta-analysis/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/characteristics-of-clinical-trials-evaluating-biosimilars-in-the-treatment-of-cancer-a-systematic-review-and-meta-analysis/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/biosimilar-competition-early-learning/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/new-drug-postmarketing-requirements-and-commitments-in-the-us-a-systematic-review-of-the-evidence/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/incremental-benefits-of-novel-pharmaceuticals-in-the-uk-a-cross-sectional-analysis-of-nice-technology-appraisals-from-2010-to-2020/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/indication-specific-generic-uptake-of-imatinib-demonstrates-the-impact-of-skinny-labeling/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/use-of-extrapolation-in-new-drug-approvals-by-the-us-food-and-drug-administration/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/unwanted-advice-frequency-characteristics-and-outcomes-of-negative-advisory-committee-votes-for-fda-approved-drugs/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/analysis-of-supportive-evidence-for-us-food-and-drug-administration-approvals-of-novel-drugs-in-2020/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/generating-evidence-from-expanded-access-use-of-rare-disease-medicines-challenges-and-recommendations/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/making-the-case-for-accelerated-withdrawal-of-aducanumab/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/strategies-to-manage-drugs-and-devices-approved-based-on-limited-evidence-results-of-a-modified-delphi-panel/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/hydroxyzine-initiation-following-drug-safety-advisories-on-cardiac-arrhythmias-in-the-uk-and-canada-a-longitudinal-cohort-study/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/coverage-of-new-drugs-in-medicare-part-d/ 2026-03-15T14:42:54+00:00 https://portalresearch.org/portal_work/communication-of-drug-efficacy-information-via-a-popular-online-platform/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/mifepristone-preemption-and-public-health-federalism/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/high-priced-sickle-cell-gene-therapies-threaten-to-exacerbate-us-health-disparities-and-establish-new-pricing-precedents-for-molecular-medicine/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/the-history-of-health-law-in-the-united-states/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/characteristics-of-key-patents-covering-recent-fda-approved-drugs/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/implications-of-oncology-trial-design-and-uncertainties-in-efficacy-safety-data-on-health-technology-assessments/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/therapeutic-value-of-drugs-granted-accelerated-approval-or-conditional-marketing-authorization-in-the-us-and-europe-from-2007-to-2021/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/brand-name-market-exclusivity-for-nebulizer-therapy-to-treat-asthma-and-copd/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/civil-commitment-for-opioid-misuse-do-short-term-benefits-outweigh-long-term-harms/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/antibody-patent-evolution/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/product-hopping-in-the-drug-industry-lessons-from-albuterol/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/post%e2%80%90marketing-requirements-for-cancer-drugs-approved-by-the-european-medicines-agency-2004-2014/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/payments-for-research-participation-dont-tax-the-guinea-pig/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/state-laws-and-generic-substitution-in-the-year-after-new-generic-competition/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/holding-pharmaceutical-and-medical-device-executives-accountable-as-responsible-corporate-officers/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/gastrointestinal-prophylaxis-for-covid-19-an-illustration-of-severe-bias-arising-from-inappropriate-comparators-in-observational-studies/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/variations-in-use-of-diabetes-drugs-with-cardiovascular-benefits-among-medicaid-patients/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/patent-evergreening-of-medicine-device-combination-products-a-global-perspective/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/trends-in-the-quality-of-evidence-supporting-fda-drug-approvals-results-from-a-literature-review/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/experts-views-on-fda-regulatory-standards-for-drug-and-high-risk-medical-devices-implications-for-patient-care/ 2026-03-15T14:42:55+00:00 https://portalresearch.org/portal_work/getting-the-price-right-lessons-for-medicare-price-negotiation-from-peer-countries/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/the-bayh-dole-act-at-40-accomplishments-challenges-and-possible-reforms/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/false-claims-act-prosecution-did-not-deter-off-label-drug-use-in-the-case-of-neurontin/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/decision-making-under-uncertainty-comparing-regulatory-and-health-technology-assessment-reviews-of-medicines-in-the-united-states-and-europe/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/public-approval-of-exception-from-informed-consent-in-emergency-clinical-trials-a-systematic-review-of-community-consultation-surveys/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/how-does-medical-device-regulation-perform-in-the-united-states-and-the-european-union-a-systematic-review/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/major-events-in-the-life-course-of-new-drugs-2000-2016/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/discovery-and-development-of-pregabalin-lyrica-the-role-of-public-funding/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/strategies-and-practices-in-off-label-marketing-of-pharmaceuticals-a-retrospective-analysis-of-whistleblower-complaints/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/an-international-review-of-health-technology-assessment-approaches-to-prescription-drugs-and-their-ethical-principles/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/clinical-benefit-and-expedited-approval-of-cancer-drugs-in-the-united-states-european-union-switzerland-japan-canada-and-australia/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/an-orange-book-landscape-drugs-patents-and-generic-competition/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/assessment-of-the-clinical-benefit-of-cancer-drugs-receiving-accelerated-approval/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/european-medicines-agencys-priority-medicines-scheme-at-2-years-an-evaluation-of-clinical-studies-supporting-eligible-drugs/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/a-randomized-study-of-how-physicians-interpret-research-funding-disclosures/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/fda-approval-and-regulation-of-pharmaceuticals-1983-2018/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/clinical-decision-support-systems-could-be-modified-to-reduce-alert-fatigue-while-still-minimizing-the-risk-of-litigation/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/patents-and-regulatory-exclusivities-on-inhalers-for-asthma-and-copd-1986-2020/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/industry-payments-to-physicians-are-kickbacks-how-should-stakeholders-respond/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/evidence-at-time-of-regulatory-approval-and-cost-of-new-antibiotics-in-2016-19-cohort-study-of-fda-approved-drugs/ 2026-03-15T14:42:57+00:00 https://portalresearch.org/portal_work/origins-of-medical-innovation-the-case-of-coronary-artery-stents/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/burden-of-changes-in-pill-appearance-for-patients-receiving-generic-cardiovascular-medications-after-myocardial-infarction-cohort-and-nested-case-control-studies/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/patterns-and-predictors-of-generic-narrow-therapeutic-index-drug-use-among-older-adults/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/rates-and-costs-of-dispensing-naloxone-to-patients-at-high-risk-for-opioid-overdose-in-the-united-states-2014-2018/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/ethical-and-legal-views-of-physicians-regarding-deactivation-of-cardiac-implantable-electrical-devices-a-quantitative-assessment/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/preferences-for-and-experiences-with-pill-appearance-changes-national-surveys-of-patients-and-pharmacists/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/modified-regulatory-pathways-to-approve-generic-drugs-in-the-us-and-a-systematic-review-of-their-outcomes/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/a-new-wave-of-vaccines-for-non-communicable-diseases-what-are-the-regulatory-challenges/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/battling-over-patents-the-impact-of-oil-states-on-the-generic-drug-industry/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/prevalence-of-publicly-available-expanded-access-policies/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/drug-development-and-fda-approval-1938-2013/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/assessment-of-prices-for-cardiovascular-tests-and-procedures-at-top-ranked-us-hospitals/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/the-505b2-drug-approval-pathway/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/health-policy-basics-the-physician-payment-sunshine-act-and-the-open-payments-program/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/existing-fda-pathways-have-potential-to-ensure-early-access-to-and-appropriate-use-of-specialty-drugs/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/luxturna-fda-documents-reveal-the-value-of-a-costly-gene-therapy/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/market-based-licensing-for-hpv-vaccines-in-developing-countries/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/competition-law-and-pricing-among-biologic-drugs-the-case-of-vegf-therapy-for-retinal-diseases/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/a-multi-modal-approach-to-evaluate-the-impact-of-risk-evaluation-and-mitigation-strategy-rems-programs/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/methodological-approaches-to-evaluate-the-impact-of-fda-drug-safety-communications/ 2026-03-15T14:42:58+00:00 https://portalresearch.org/portal_work/designing-comparative-effectiveness-research-on-prescription-drugs-lessons-from-the-clinical-trial-literature/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/the-consequences-of-requesting-dispense-as-written/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/secondary-patenting-of-branded-pharmaceuticals-a-case-study-of-how-patents-on-two-hiv-drugs-could-be-extended-for-decades/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/the-high-cost-of-prescription-drugs-in-the-united-states-origins-and-prospects-for-reform/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/a-matter-of-trust-patient-barriers-to-primary-medication-adherence/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/using-patent-data-to-assess-the-value-of-pharmaceutical-innovation/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/patient-and-caregiver-experiences-with-and-perceptions-of-risk-evaluation-and-mitigation-strategy-programs-with-elements-to-assure-safe-use/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/raising-medicaid-rebates-for-drugs-with-accelerated-approval/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/predictors-of-drug-shortages-and-association-with-generic-drug-prices-a-retrospective-cohort-study/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/multimodal-analysis-of-fda-drug-safety-communications-lessons-from-zolpidem/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/generic-but-expensive-why-prices-can-remain-high-for-off-patent-drugs/ 2026-03-15T14:43:00+00:00 https://portalresearch.org/portal_work/transferrable-market-exclusivity-extensions-to-promote-antibiotic-development-an-economic-analysis/ 2026-03-15T14:50:00+00:00 https://portalresearch.org/portal_work/a-qualitative-study-of-biosimilar-manufacturer-and-regulator-perceptions-on-intellectual-property-and-abbreviated-approval-pathways/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/efficacy-and-costs-of-spinal-muscular-atrophy-drugs/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/social-cultural-and-economic-aspects-of-antimicrobial-resistance/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/reducing-prescription-drug-costs-policy-options-for-a-public-plan/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/generic-competition-for-drugs-treating-rare-diseases/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/beyond-the-high-prices-of-prescription-drugs-a-framework-to-assess-costs-resource-allocation-and-public-funding/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/trends-in-medicare-part-d-inhaler-spending-2012-2018/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/federal-spending-on-off-patent-drugs-that-lack-generic-competition/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/ashp-foundation-pharmacy-forecast-2021-strategic-planning-advice-for-pharmacy-departments-in-hospitals-and-health-systems/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/characteristics-of-postmarketing-studies-for-vaccines-approved-by-the-us-food-and-drug-administration-2006-2020/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/identifying-potential-prescription-drug-product-hopping/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/a-non-profit-approach-to-address-foreign-dependence-of-generic-drugs/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/characteristics-of-clinical-trials-launched-early-in-the-covid-19-pandemic-in-the-us-and-in-france/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/public-sector-and-non-profit-contributions-to-drug-development-historical-scope-opportunities-and-challenges/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/the-wrong-cure-financial-incentives-for-unimpressive-new-antibiotics/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/association-of-californias-prescription-drug-coupon-ban-with-generic-drug-use/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/over-the-counter-monograph-safety-innovation-and-reform-act/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/frequency-of-first-generic-drug-approvals-with-skinny-labels-in-the-united-states/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/market-exclusivity-and-changes-in-competition-and-prices-associated-with-the-us-food-and-drug-administration-unapproved-drug-initiative/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/variations-in-generic-combination-opioid-use-across-state-medicaid-programs/ 2026-03-15T17:22:05+00:00 https://portalresearch.org/portal_work/changing-fda-approval-standards-ethical-implications-for-patient-consent/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/public-sector-contributions-to-novel-biologic-drugs/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/medicare-spending-on-drugs-with-accelerated-approval-2015-2019/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/payer-specific-negotiated-prices-for-prescription-drugs-at-top-performing-us-hospitals/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/the-characteristics-of-patents-impacting-availability-of-biosimilars/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/promoting-competition-in-drug-pricing-a-review-of-recent-congressional-legislation/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/medicaid-spending-on-drugs-marketed-without-us-food-and-drug-administration-approval-in-2020/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/therapeutic-value-assessments-of-novel-medicines-in-the-us-and-europe-2018-2019/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/improving-the-quality-of-us-drug-patents-through-international-awareness/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/trends-in-prescription-drug-launch-prices-2008-2021/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/potential-medicare-part-d-savings-on-generic-drugs-from-the-mark-cuban-cost-plus-drug-company/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/the-vexing-voyage-of-vasopressin/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/what-should-us-policymakers-learn-from-international-drug-pricing-transparency-strategies/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/fulfillment-of-postmarket-commitments-and-requirements-for-new-drugs-approved-by-the-fda-2013-2016/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/medicaid-expenditures-and-estimated-rebates-on-line-extension-drugs-2010-2018/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/the-swinging-pendulum-the-supreme-court-reverses-course-on-erisa-and-managed-care/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/medical-process-patents-monopolizing-the-delivery-of-health-care/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/scientific-and-legal-viability-of-follow-on-protein-drugs/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/expert-review-of-drug-patent-applications-improving-health-in-the-developing-world/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/improving-antibiotic-markets-for-long-term-sustainability/ 2026-03-15T17:22:07+00:00 https://portalresearch.org/portal_work/pay-for-delay-settlements-of-disputes-over-pharmaceutical-patents/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/full-coverage-for-preventive-medications-after-myocardial-infarction/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/meta-analyses-involving-cross-over-trials-methodological-issues/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/regulation-of-medical-devices-in-the-united-states-and-european-union/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/changes-in-direct-to-consumer-pharmaceutical-advertising-following-shifts-from-prescription-only-to-over-the-counter-status/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/effect-of-financial-relationships-on-the-behaviors-of-health-care-professionals-a-review-of-the-evidence/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/the-ethics-of-intellectual-property-rights-in-an-era-of-globalization/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/crowdsourcing-clinical-trials/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/postmarket-surveillance-of-medical-devices-a-comparison-of-strategies-in-the-us-eu-japan-and-china/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/approval-and-withdrawal-of-new-antibiotics-and-other-antiinfectives-in-the-us-1980-2009/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/assessment-of-us-pathway-for-approving-medical-devices-for-rare-conditions/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/new-fda-breakthrough-drug-category-implications-for-patients/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/crowdsourcing-public-health-experiments-a-response-to-jonathan-darrows-crowdsourcing-clinical-trials/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/fda-regulation-of-mobile-health-technologies/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/pharmaceutical-gatekeepers/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/medical-device-postapproval-safety-monitoring-where-does-the-united-states-stand/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/practical-legal-and-ethical-issues-in-expanded-access-to-investigational-drugs/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/paying-for-innovation-reimbursement-incentives-for-antibiotics/ 2026-03-15T17:22:09+00:00 https://portalresearch.org/portal_work/paying-physicians-to-prescribe-generic-drugs-and-follow-on-biologics-in-the-united-states/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/variations-in-time-of-market-exclusivity-among-top-selling-prescription-drugs-in-the-united-states/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/propofol-as-a-transformative-drug-in-anesthesia-insights-from-key-early-investigators/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/forbidden-and-permitted-statements-about-medications-loosening-the-rules/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/fda-policy-and-cardiovascular-medicine/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/trends-in-utilization-of-fda-expedited-drug-development-and-approval-programs-1987-2014-cohort-study/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/experience-with-the-priority-review-voucher-program-for-drug-development/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/cost-effectiveness-of-statin-therapy-for-ascvd/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/two-decades-of-new-drug-development-for-central-nervous-system-disorders/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/an-uninformative-truth-the-logic-of-amarins-off-label-promotion/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/physicians-knowledge-about-fda-approval-standards-and-perceptions-of-the-breakthrough-therapy-designation/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/prevalence-and-predictors-of-generic-drug-skepticism-among-physicians-results-of-a-national-survey/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/assessing-the-gold-standard-lessons-from-the-history-of-rcts/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/federal-circuit-review-of-uspto-inter-partes-review-decisions-by-the-numbers/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/countering-imprecision-in-precision-medicine/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/generic-drug-approvals-since-the-1984-hatch-waxman-act/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/biomarker-defined-subsets-of-common-diseases-policy-and-economic-implications-of-orphan-drug-act-coverage/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/medicaid-expenditures-and-estimated-rebates-for-epinephrine-autoinjectors-2012-to-2016/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/journey-of-generic-imatinib-a-case-study-in-oncology-drug-pricing/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/the-opioid-epidemic-fixing-a-broken-pharmaceutical-market/ 2026-03-15T17:22:11+00:00 https://portalresearch.org/portal_work/association-of-the-priority-review-voucher-with-neglected-tropical-disease-drug-and-vaccine-development/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/the-fdas-expedited-programs-and-clinical-development-times-for-novel-therapeutics-2012-2016/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/speed-safety-and-industry-funding-from-pdufa-i-to-pdufa-vi/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/prices-of-generic-drugs-associated-with-numbers-of-manufacturers/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/research-ethics-for-emerging-trial-designs-does-equipoise-need-to-adapt/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/tertiary-patenting-on-drug-device-combination-products-in-the-united-states/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/studying-new-antibiotics-for-multidrug-resistant-infections-are-todays-patients-paying-for-unproved-future-benefits/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/the-fda-breakthrough-drug-designation-four-years-of-experience/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/availability-of-pediatric-information-in-european-medicines-agency-approvals/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/expansion-of-the-priority-review-voucher-program-under-the-21st-century-cures-act-implications-for-innovation-and-public-health/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/application-and-impact-of-run-in-studies-for-the-evaluation-of-statin-efficacy-and-safety/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/effectiveness-and-value-of-2-novel-treatments-for-tardive-dyskinesia/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/changes-in-drug-pricing-after-drug-shortages-in-the-united-states/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/internal-medicine-physicians-financial-relationships-with-industry-an-updated-national-estimate/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/approximating-future-generic-entry-for-new-drugs/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/cost-implications-of-escalating-intravenous-acetaminophen-use-in-children/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/physicians-perspectives-on-fda-approval-standards-and-off-label-drug-marketing/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/pre-market-development-times-for-biologic-versus-small-molecule-drugs/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/price-increases-of-protected-class-drugs-in-medicare-part-d-relative-to-inflation-2012-2017/ 2026-03-15T17:22:13+00:00 https://portalresearch.org/portal_work/why-are-biosimilars-not-living-up-to-their-promise-in-the-us/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/promoting-pediatric-drug-research-and-labeling-outcomes-of-legislation/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/changes-in-price-for-generic-drugs-in-the-usa-2008-2016/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/lung-cancer-survival-gains-contributions-of-academia-and-industry/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/surrogate-endpoints-and-drug-regulation-what-is-needed-to-clarify-the-evidence/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/characteristics-of-recent-generic-drug-approvals-by-the-us-food-and-drug-administration/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/impact-of-state-laws-restricting-opioid-duration-on-characteristics-of-new-opioid-prescriptions/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/potential-medicare-savings-from-generic-substitution-and-therapeutic-interchange-of-ace-inhibitors-and-angiotensin-ii-receptor-blockers/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/changes-in-utilization-of-generic-angiotensin-receptor-blockers-following-product-recalls-in-the-united-states/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/potential-medicare-savings-on-inhaler-prescriptions-through-the-use-of-negotiated-prices-and-a-defined-formulary/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/estimation-of-medicare-part-d-spending-on-insulin-for-patients-with-diabetes-using-negotiated-prices-and-a-defined-formulary/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/evaluating-the-evidence-behind-the-surrogate-measures-included-in-the-fdas-table-of-surrogate-endpoints-as-supporting-approval-of-cancer-drugs/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/communicating-emerging-risks-of-sglt2-inhibitors-timeliness-and-transparency-of-medicine-regulators/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/expedited-regulatory-review-of-low-value-drugs/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/fda-and-ema-biosimilar-approvals/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/utilization-and-treatment-costs-of-tumor-necrosis-factor-inhibitors-after-the-introduction-of-biosimilar-infliximab-in-the-united-states/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/novelty-of-active-ingredients-in-high-cost-brand-name-drugs/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/internet-searches-for-unproven-covid-19-therapies-in-the-united-states/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/false-negative-tests-for-sars-cov-2-infection-challenges-and-implications/ 2026-03-15T17:22:14+00:00 https://portalresearch.org/portal_work/origins-and-ownership-of-remdesivir-implications-for-pricing/ 2026-03-15T17:22:16+00:00 https://portalresearch.org/portal_work/drug-shortages-and-the-defense-production-act/ 2026-03-15T17:22:16+00:00 https://portalresearch.org/portal_work/accounting-for-us-public-funding-in-drug-development-how-can-we-better-balance-access-affordability-and-innovation/ 2026-03-15T17:22:16+00:00 https://portalresearch.org/portal_work/producing-and-using-timely-comparative-evidence-on-drugs-lessons-from-clinical-trials-for-covid-19/ 2026-03-15T17:22:16+00:00 https://portalresearch.org/portal_work/characteristics-of-us-patients-and-prescribers-using-hydroxychloroquine-during-the-covid-19-pandemic/ 2026-03-15T17:22:16+00:00 https://portalresearch.org/portal_work/medical-innovation-then-and-now-perspectives-of-innovators-responsible-for-transformative-drugs/ 2026-03-15T17:29:26+00:00 https://portalresearch.org/portal_work/sponsorship-and-funding-for-gene-therapy-trials-in-the-united-states/ 2026-03-15T17:30:15+00:00 https://portalresearch.org/portal_work/evolution-of-insulin-patents-and-market-exclusivities-in-the-usa/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/new-treatments-for-migraine-therapeutic-ratings-and-comparative-coverage-in-the-us-canada-and-europe/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/review-times-and-adverse-events-for-cardiovascular-devices/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/negative-phase-3-randomized-controlled-trials-why-cancer-drugs-fail-the-last-barrier/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/benefits-limitations-and-value-of-abuse-deterrent-opioids/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/does-helicobacter-pylori-eradication-therapy-to-prevent-gastric-cancer-increase-all%e2%80%90cause-mortality/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/distributions-of-industry-payments-to-massachusetts-physicians/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/off-label-drug-use-and-promotion-balancing-public-health-goals-and-commercial-speech/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/us-taxpayers-heavily-funded-the-discovery-of-covid%e2%80%9019-vaccines/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/the-price-of-crossing-the-border-for-medications/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/simplify-drug-labelling-to-show-benefits-clearly/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/few-new-drugs-deserve-expedited-regulatory-treatment/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/the-perils-of-increasing-medicaid-rebates-for-drugs-with-accelerated-approval/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/government-pharmaceutical-development-to-address-high-prices-challenges-ahead/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/why-high-drug-pricing-is-a-problem-for-research-ethics/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/ethical-challenges-in-biomarker-driven-drug-development/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/payments-to-physicians-prescribing-rates-and-more-appropriate-conclusions-reply/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/the-price-of-crossing-the-border-for-medications-reply/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/risks-to-the-340b-drug-pricing-program-reply/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/inaccurate-reporting-of-insulin-reimbursement-reply/ 2026-03-16T19:39:42+00:00 https://portalresearch.org/portal_work/fda-approval-of-eteplirsen-for-muscular-dystrophy-reply/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/practical-legal-and-ethical-issues-in-expanded-access-to-investigational-drugs-reply/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/applying-academic-detailing-and-process-change-to-promote-choosing-wisely/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/evidence-required-for-drugs-granted-accelerated-approval-reply/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/the-backlash-against-bioequivalence-and-the-interchangeability-of-brand-name-and-generic-drugs/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/permitting-product-liability-litigation-for-fda-approved-drugs-and-devices-promotes-patient-safety/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/priority-review-vouchers-an-inefficient-and-dangerous-way-to-promote-neglected-disease-drug-development/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/drug-company-gifts-to-medical-students-the-hidden-curriculum/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/rising-health-care-costs-and-life-cycle-management-in-the-pharmaceutical-market/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/covert-pharmaceutical-promotion-in-free-medical-journals/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/variability-in-global-drug-prices/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/aducanumab-and-accelerated-approval-where-do-we-go-from-here/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/opioid-crisis-in-the-us-lessons-from-western-europe/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/an-export-only-exception-to-pharmaceutical-patents-in-europe-should-the-united-states-follow-suit/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/public-referendum-on-drug-prices-in-the-us-will-it-bring-relief/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/user-fees-and-beyond-the-fda-safety-and-innovation-act-of-2012/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/government-patent-use-to-promote-public-health-in-the-united-states-overcoming-nonpatent-exclusivities/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/the-evolving-role-of-biomarker-patents-in-personalized-medicine/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/eliminating-coverage-discrimination-through-the-essential-health-benefits-anti-discrimination-provisions/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/massachusetts-proposed-medicaid-reforms-cheaper-drugs-and-better-coverage/ 2026-03-16T19:39:43+00:00 https://portalresearch.org/portal_work/legal-challenges-to-state-drug-pricing-laws/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/recent-orange-and-purple-book-legislation-suggests-a-need-to-bridge-drug-and-biologic-patent-regimes/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/state-initiatives-to-control-medication-costs-can-transparency-legislation-help/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/will-ending-the-medicaid-drug-rebate-cap-lower-drug-prices/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/the-us-food-and-drug-administration-515-program-initiative-addressing-the-evidence-gap-for-widely-used-high-risk-cardiovascular-devices/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/balancing-access-and-innovation-indias-supreme-court-rules-on-imatinib/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/new-reforms-to-prescription-drug-pricing-in-the-us-opportunities-and-challenges/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/regulating-off-label-promotion-a-critical-test/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/fda-regulation-of-off-label-drug-promotion-under-attack/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/both-urgency-and-balance-needed-in-addressing-opioid-epidemic-a-report-from-the-national-academies-of-sciences-engineering-and-medicine/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/regulatory-decision-making-on-covid-19-vaccines-during-a-public-health-emergency/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/the-supreme-court-preemption-and-malpractice-liability/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/the-supreme-courts-latest-ruling-on-drug-liability-and-its-implications-for-future-failure-to-warn-litigation/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/gene-patenting-the-supreme-court-finally-speaks/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/biomarkers-unbound-the-supreme-courts-ruling-on-diagnostic-test-patents/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/the-supreme-court-ruling-in-sandoz-v-amgen-a-victory-for-follow-on-biologics/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/the-trans-pacific-partnership-agreement-and-implications-for-access-to-essential-medicines/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/the-future-of-drug-pricing-transparency/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/active-surveillance-of-follow-on-biologics-a-prescription-for-uptake/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/lifecycle-regulation-of-artificial-intelligence-and-machine-learning-based-software-devices-in-medicine/ 2026-03-16T19:39:45+00:00 https://portalresearch.org/portal_work/cell-and-gene-therapy-trials-are-we-facing-an-evidence-crisis/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/cost-effectiveness-of-aducanumab-and-donanemab-for-early-alzheimer-disease-estimating-the-true-value/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/how-patent-troll-legislation-can-increase-timely-access-to-generic-drugs/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/promoting-biosimilar-competition-by-revising-medicare-reimbursement-rules/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/removing-erisas-impediment-to-state-health-reform/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/increasing-access-to-fda-inspection-reports-on-irregularities-and-misconduct-in-clinical-trials/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/performance-linked-reimbursement-and-the-uncertainty-of-novel-drugs/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/the-implications-of-industry-funded-disease-awareness-campaigns-in-the-rare-disease-setting/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/reforming-patient-cost-sharing-for-cancer-medications-in-medicare-part-d/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/coverage-of-magnetic-resonance-imaging-for-patients-with-cardiac-devices-improving-the-coverage-with-evidence-development-program/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/right-to-try-requests-and-oncologists-gatekeeping-obligations/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/getting-the-right-evidence-after-drug-approval/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/the-role-of-litigation-in-defining-drug-risks/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/balancing-innovation-access-and-profits-market-exclusivity-for-biologics/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/state-restrictions-on-mifepristone-access-the-case-for-federal-preemption/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/fulfilling-the-mandate-of-the-us-food-and-drug-administrations-accelerated-approval-pathway-the-need-for-reforms/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/designing-development-programs-for-non-traditional-antibacterial-agents/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/ethical-and-practical-considerations-in-removing-black-box-warnings-from-drug-labels/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/the-us-food-and-drug-administrations-approval-of-adjuvant-sunitinib-for-renal-cell-cancer-a-case-of-regulatory-capture/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/us-food-and-drug-administration-approval-of-new-drugs-based-on-noninferiority-trials-in-oncology-a-dangerous-precedent/ 2026-03-16T19:39:46+00:00 https://portalresearch.org/portal_work/ensuring-safe-access-to-mifepristone-during-the-pandemic-and-beyond/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/a-new-way-to-contain-unaffordable-medication-costs-exercising-the-governments-existing-rights/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/reforming-the-orphan-drug-act-for-the-21st-century/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/defining-true-and-non-misleading-for-pharmaceutical-promotion/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/new-and-unproved-medical-devices/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/regulating-incremental-innovation-in-medical-devices/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/grounding-value%e2%80%90based-drug-pricing-in-population-health/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/the-fda-juno-therapeutics-and-the-ethical-imperative-of-transparency/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/chemotherapy-parity-laws-a-remedy-for-high-drug-costs/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/overall-survival-as-a-primary-end-point-in-multiple-myeloma-trials/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/new-21st-century-cures-legislation-speed-and-ease-vs-science/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/reporting-bias-in-clinical-trials-progress-toward-transparency-and-next-steps/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/progress-and-hurdles-for-follow-on-biologics/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/will-strict-limits-on-opioid-prescription-duration-prevent-addiction-advocating-for-evidence-based-policymaking/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/breakthrough-medical-devices-and-the-21st-century-cures-act/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/revisiting-fda-approval-of-aducanumab/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/rethinking-global-access-to-vaccines/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/drug-labels-a-flawed-source-of-data-for-studying-orphan-drug-approvals/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/the-failure-of-solanezumab-how-the-fda-saved-taxpayers-billions/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/periodic-benefit%e2%80%90risk-evaluation-reports-have-substantial-promise-to-guide-patient-care-and-should-be-made-publicly-available/ 2026-03-16T19:39:48+00:00 https://portalresearch.org/portal_work/fda-approval-of-desmopressin-for-nocturia/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/approving-a-problematic-muscular-dystrophy-drug-implications-for-fda-policy/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/need-for-transparency-and-reliable-evidence-in-emergency-use-authorizations-for-coronavirus-disease-2019-covid-19-therapies/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/missed-opportunities-on-emergency-remdesivir-use/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/mitigating-health-risks-of-prescription-drugs-lessons-from-fda-oversight-of-opioid-products/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/tepid-steps-on-drug-pricing/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/an-incomplete-prescription-president-trumps-plan-to-address-high-drug-prices/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/incentives-for-drug-development-the-curious-case-of-colchicine/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/orphan-drug-designation-and-exclusivity-for-same-drugs/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/will-inter-partes-review-speed-us-generic-drug-entry/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/product-specific-regulatory-pathways-to-approve-generic-drugs-the-need-for-follow-up-studies-to-ensure-safety-and-effectiveness/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/value-based-pricing-and-state-reform-of-prescription-drug-costs/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/a-new-approach-to-treat-childhood-leukemia-novartis-car-t-therapy/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/ensuring-patient-privacy-in-data-sharing-for-postapproval-research/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/promoting-confidence-in-cost-effectiveness-analyses/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/the-21st-century-cures-act-opportunities-and-challenges/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/reinforcing-the-social-compromise-of-accelerated-approval/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/gene-patenting-is-the-pendulum-swinging-back/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/trust-and-transparency-in-medical-device-regulation/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/limitations-on-the-capability-of-the-fda-to-advise/ 2026-03-16T19:39:50+00:00 https://portalresearch.org/portal_work/insulin-access-and-affordability-in-the-usa-anticipating-the-first-interchangeable-insulin-product/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/drug-evaluation-during-the-covid-19-pandemic/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/the-safety-of-prescription-drugs/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/continual-learning-in-medical-devices-fdas-action-plan-and-beyond/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/value-based-pricing-of-drugs-with-multiple-indications-or-in-combinations-lessons-from-europe/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/risks-to-the-340b-drug-pricing-program-related-to-manufacturer-restrictions-on-drug-availability/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/ensuring-access-to-injectable-generic-drugs-the-case-of-intravesical-bcg-for-bladder-cancer/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/the-shortage-of-normal-saline-in-the-wake-of-hurricane-maria/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/using-a-drug-safety-tool-to-prevent-competition/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/strategies-to-improve-the-affordability-of-insulin-in-the-usa/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/the-promise-of-escat-a-new-system-for-evaluating-cancer-drug-target-pairs/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/the-effects-of-the-sunshine-act-what-can-and-should-we-expect/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/the-food-and-drug-administrations-role-in-promoting-consistent-labels-for-generic-drugs/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/regulatory-solutions-to-the-problem-of-high-generic-drug-costs/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/fool-me-twice-the-reemergence-of-rofecoxib-and-the-orphan-drug-act/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/implementing-u-s-covid-19-testing-regulatory-and-infrastructural-challenges/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/pharmaceutical-marketing-and-the-new-social-media/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/patient-assistance-programs-and-the-anti-kickback-statute-charting-a-pathway-forward/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/safeguarding-evidence-based-decision-making-in-the-fda-for-covid-19-vaccines/ 2026-03-16T19:39:51+00:00 https://portalresearch.org/portal_work/specialty-drugs-a-distinctly-american-phenomenon/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/preventing-medical-device-borne-outbreaks-high-level-disinfection-policy-for-duodenoscopes/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/the-medical-device-excise-tax-over-before-it-begins/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/what-is-the-publics-right-to-access-medical-discoveries-based-on-federally-funded-research/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/updating-the-bayh-dole-act-march-in-rights-and-transparency/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/pharmaceutical-advertising-in-medical-journals/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/prescription-drug-coupons-no-such-thing-as-a-free-lunch/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/challenges-and-opportunities-for-biomarker-validation/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/direct-to-consumer-generic-drugs-a-maverick-approach-or-another-exposure-of-market-failures/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/promoting-therapeutic-innovation-what-do-we-do-about-drug-device-combinations/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/balancing-benefits-and-harms-privacy-protection-policies/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/accelerated-approval-and-expensive-drugs-a-challenging-combination/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/antitrust-market-exclusivity-and-transparency-in-the-pharmaceutical-industry/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/real-world-evidence-and-regulatory-drug-approval/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/who-is-now-responsible-for-discovering-and-warning-about-adverse-effects-of-generic-drugs/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/paying-patients-for-their-tissue-the-legacy-of-henrietta-lacks/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/biomedical-patents-and-the-publics-health-is-there-a-role-for-eminent-domain/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/the-21st-century-cures-act-will-it-take-us-back-in-time/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/navigating-the-dermatological-drug-cost-curve/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/same-song-different-audience-pharmaceutical-promotion-targeting-non-physician-health-care-providers/ 2026-03-16T19:39:53+00:00 https://portalresearch.org/portal_work/up-is-down-pharmaceutical-industry-caution-vs-federal-acceleration-of-covid-19-vaccine-approval/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/fda-approval-standards-for-anticancer-agents-lessons-from-two-recent-approvals-in-breast-cancer/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/integrating-new-effectiveness-data-into-us-food-and-drug-administration-approved-drug-labeling/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/three-design-aspects-for-high-quality-post-marketing-cohort-studies/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/introduction-to-a-supplement-on-innovative-approaches-to-studying-health-outcomes-in-rare-diseases/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/insights-from-a-national-conference-conflicts-of-interest-in-the-practice-of-medicine/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/reforming-the-world-health-organizations-essential-medicines-list-essential-but-unaffordable/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/paying-for-prescription-drugs-in-the-new-administration/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/promoting-patient-interests-in-implementing-the-federal-right-to-try-act/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/translational-research-and-the-u-s-federal-elections/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/development-of-a-national-public-pharmaceutical-research-and-development-institute/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/switching-to-over-the-counter-availability-of-rescue-inhalers-for-asthma/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/the-case-for-reforming-drug-naming-should-brand-name-trademark-protections-expire-upon-generic-entry/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/role-of-authorized-generics-in-postapproval-surveillance-of-generic-drug-products/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/accelerating-innovation-in-rapid-diagnostics-and-targeted-antibacterials/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/use-the-bayh-dole-act-to-lower-drug-prices-for-government-healthcare-programs/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/the-evidence-landscape-in-precision-medicine/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/government-patent-use-to-address-the-rising-cost-of-naloxone-28-u-s-c-%c2%a7-1498-and-evzio/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/questions-about-the-10-x-20-initiative/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/covid-19-vaccine-boosters-for-all-adults-an-optimal-u-s-approach/ 2026-03-16T19:39:54+00:00 https://portalresearch.org/portal_work/u-s-food-and-drug-administration-precertification-pilot-program-for-digital-health-software-weighing-the-benefits-and-risks/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/the-u-s-insulin-crisis-rationing-a-lifesaving-medication-discovered-in-the-1920s/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/pharmaceutical-protections-in-u-s-trade-deals-what-do-americans-get-in-return/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/regulating-homeopathic-products-a-century-of-dilute-interest/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/the-watchman-saga-closure-at-last/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/using-real%e2%80%90world-safety-data-in-regulatory-approval-decisions-sotagliflozin-and-the-risk-of-diabetic-ketoacidosis/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/the-next-forum-for-unraveling-fda-off-label-marketing-rules-state-and-federal-legislatures/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/the-regulatory-accountability-act-of-2017-implications-for-fda-regulation-and-public-health/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/reforms-to-accelerated-approval-of-new-medicines-long-overdue/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/covid-19-antivirals-must-not-affect-hiv-drug-supply/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/conflict-of-interest-disclosure-in-early-education-of-medical-students/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/precision-medicine-and-the-fdas-draft-guidance-on-laboratory-developed-tests/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/underrepresentation-of-older-adults-in-cancer-trials/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/drug-prices-rebates-and-discounts/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/improving-evidence-based-practices-through-health-literacy/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/a-hemorrhage-of-off-label-use/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/the-emergence-of-the-randomized-controlled-trial/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/what-to-know-about-the-alzheimer-drug-aducanumab-aduhelm/ 2026-03-16T19:39:56+00:00